4//SEC Filing
McDonough Brian 4
Accession 0000899243-22-004128
CIK 0001596946other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:05 PM ET
Size
23.5 KB
Accession
0000899243-22-004128
Insider Transaction Report
Form 4
Quotient LtdQTNT
McDonough Brian
Director
Transactions
- Sale
Ordinary Shares
2022-01-31−1,886→ 66,901 total - Exercise/Conversion
Ordinary Shares
2022-01-31+6,917→ 68,787 total - Exercise/Conversion
Restricted Stock Units
2022-01-31−6,917→ 20,751 total→ Ordinary Shares (6,917 underlying)
Holdings
- 9,597
Ordinary Shares Option (Right to buy)
Exercise: $5.21Exp: 2027-10-31→ Ordinary Shares (9,597 underlying) - 8,158
Ordinary Shares Option (Right to buy)
Exercise: $7.78Exp: 2029-10-31→ Ordinary Shares (8,158 underlying) - 10,000
Ordinary Shares Option (Right to buy)
Exercise: $8.00Exp: 2024-04-29→ Ordinary Shares (10,000 underlying) - 5,025
Ordinary Shares Option (Right to buy)
Exercise: $9.95Exp: 2024-10-31→ Ordinary Shares (5,025 underlying) - 8,726
Ordinary Shares Option(Right to buy)
Exercise: $5.73Exp: 2026-10-31→ Ordinary Shares (8,726 underlying) - 6,240
Ordinary Shares Option (Right to buy)
Exercise: $6.41Exp: 2028-10-31→ Ordinary Shares (6,240 underlying) - 13,611
Ordinary Share Option(Right to Buy)
Exercise: $4.55Exp: 2030-10-31→ Ordinary Shares (13,611 underlying) - 53,040(indirect: By Trust)
Ordinary Shares
- 40,029
Options to purchase ordinary shares
From: 2014-11-14Exp: 2022-08-30→ Ordinary Shares (40,029 underlying) - 4,303
Ordinary Shares Option(Right to buy)
Exercise: $11.62Exp: 2025-10-31→ Ordinary Shares (4,303 underlying) - 24,040
Ordinary Share Option (Right to Buy)
Exercise: $2.53Exp: 2031-10-31→ Ordinary Shares (24,040 underlying)
Footnotes (14)
- [F1]All 10,000 options have vested and remain exercisable.
- [F10]2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022.
- [F11]All 13,611 options have vested and remain exercisable.
- [F12]On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 6,917 have vested and have converted into ordinary shares. The remaining 20,751 restricted stock units will vest in three equal installments on April 30, 2022, July 31, 2022 and October 31, 2022.
- [F13]The options vest and become exercisable on October 31, 2022.
- [F14]The sale reported on this Form 4 is a sale to cover taxes arising from the vesting and settlement of RSU awards. This sale is mandated by the Reporting Person's election to fund such taxes by completing a"sell to cover" transaction with a brokerage firm designated by the Issuer.
- [F2]The exercise price will be paid in pounds sterling, at GBP 0.91 per share.
- [F3]All 5,025 options have vested and remain exercisable.
- [F4]All 4,303 options have vested and remain exercisable.
- [F5]All 8,726 options have vested and remain exercisable.
- [F6]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
- [F7]All 9,597 options have vested and remain exercisable.
- [F8]All 6,240 options have vested and remain exercisable.
- [F9]The Reporting Person and his spouse are Co-Trustees of their successors in trust, of the McDonough-McGuire Joint Revocable Trust, dated May 14, 2013. The Reporting Person disclaims beneficialownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these ordinary shares in this report shall not be deemed an admission of beneficial ownership of all of thereported ordinary shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Quotient Ltd
CIK 0001596946
Entity typeother
Related Parties
1- filerCIK 0001605065
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:05 PM ET
- Size
- 23.5 KB